Impaired interleukin-8-induced degranulation of polymorphonuclear neutrophils from human immunodeficiency virus type 1-infected individuals

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 3, 1999, Pages 345-351

  Meddows Taylor, Stephen ^a   Martin, Desmond J ^a   Tiemessen, Caroline T ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8;

ADULT; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEGRANULATION; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MYCOBACTERIUM; NEUTROPHIL; PNEUMOCYSTIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STREPTOCOCCUS;

EID: 0032964992     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.3.345-351.1999     Document Type: Article

References (34)

1. Chen, T. P., R. L. Roberts, K. G. Wu, B. J. Ank, and E. R. Stiehm. 1993. Decreased superoxide anion and hydrogen peroxide production by neutrophils and monocytes in human immunodeficiency virus-infected children and adults. Pediat. Res. 34:544-550.
2. Chuntharapai, A., J. Lee, C. A. Hébert, and K. J. Kim. 1994. Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J. Immunol. 153:5682-5688.
3. Colotta, F., F. Re, N. Polentarutti, S. Sozzani, and A. Mantovani. 1992. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012-2020.
4. Dahinden, C. A., J. Zingg, F. E. Maly, and A. L. de Weck. 1988. Leukotriene production in human neutrophils primed by recombinant human granulocyte macrophage colony-stimulating factor and stimulated with complement component C5a and FMLP as second signals. J. Exp. Med. 167:1281-1295.
5. Damiano, V. V., U. Kucich, E. Murer, N. Laudenslager, and G. Weinbaum. 1988. Ultrastructural quantitation of peroxidase- and elastase-containing granules in human neutrophils. Am. J. Pathol. 131:235-245.
6. 2 activation in human neutrophils. Immunology 75:157-163.
7. Dransfield, I., A.-M. Buckle, J. S. Savill, A. McDowall, C. Haslett, and N. Hogg. 1994. Neutrophil apoptosis is associated with a reduction in CD16 (FcγRIII) expression. J. Immunol. 153:1254-1263.
8. Ellis, M., S. Gupta, S. Galant, S. Hakim, C. VandeVen, C. Toy, and M. S. Cairo. 1988. Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. J. Infect. Dis. 158:1268-1276.
9. Huizinga, T. W. J., K. M. Dolman, N. J. M. van der Linden, M. Kleijer, J. H. Nuijens, A. E. G. K. von dem Borne, and D. Roos. 1990. Phosphatidylinositol-linked FcRIII mediates exocytosis of neutrophil granule proteins, but does not mediate initiation of the respiratory burst. J. Immunol. 144:1432-1437.
10. Jentsch, U. 1997. A review of opportunistic infections in Africa. South Afr. J. Epidemiol. Infect. 12:28-32.
11. Jones, S. A., M. Wolf, S. Qin, C. R. Mackay, and M. Baggiolini. 1996. Different functions for the interleukin-8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc. Natl. Acad. Sci. USA 93:6682-6686.
12. Kew, R. R., C. M. Grimaldi, M. B. Furie, and H. B. Fleit. 1992. Human neutrophils FcγRIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis. J. Immunol. 149:989-997.
13. Lazzerin, A., C. Uberti Foppa, M. Galli, A. Mantovani, G. Poli, F. Franzetti, and R. Novati. 1986. Impairment of polymorphonuclear leukocyte function in patients with acquired immunodeficiency syndrome and lymphadenopathy syndrome. Clin. Exp. Immunol. 65:105-111.
14. Lee, A., M. K. B. Whyte, and C. Haslett. 1993. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukocyte Biol. 54:283-288.
15. Lehrer, R. I., and T. Ganz. 1990. Antimicrobial polypeptides in human neutrophils. Blood 76:2169-2181.
16. Matsumoto, T., T. Miike, R. P. Nelson, W. L. Trudeau, R. F. Lockey, and J. Yodoi. 1993. Elevated serum levels of IL-8 in patients with HIV infection. Clin. Exp. Immunol. 93:149-151.
17. McColl, S. R., D. Beauseigle, C. Gilbert, and P. H. Naccache. 1990. Priming of the human neutrophil respiratory burst by granulocyte macrophage colony-stimulating factor and tumour necrosis factor-α involves regulation at a post cell-surface receptor level. J. Immunol. 145:3047-3053.
18. Meddows-Taylor, S., D. J. Martin, and C. T. Tiemessen. 1997. Altered expression of FcγRIII (CD16) on polymorphonuclear neutrophils from individuals with human immunodeficiency virus type 1 disease and pulmonary tuberculosis. Clin. Diagn. Lab. Immunol. 4:789-791.
19. Meddows-Taylor, S., D. J. Martin, and C. T. Tiemessen. 1998. Reduced expression of interleukin-8 receptors A and B on polymorphonuclear neutrophils from persons with human immunodeficiency virus type 1 disease and pulmonary tuberculosis. J. Infect. Dis. 177:921-930.
20. Meddows-Taylor, S., D. J. Martin, and C. T. Tiemessen. Dysregulated production of interleukin-8 in individuals infected with human immunodeficiency virus type 1 and Mycobacterium tuberculosis. Infect. Immun. 67:1251-1260.
21. Murphy, P. M., H. C. Lane, A. S. Fauci, and J. I. Gallin. 1988. Impairment of neutrophil bactericidal capacity in patients with AIDS. J. Infect. Dis. 158:627-630.
22. Murray, J. F. 1989. The white plague: down and out, or up and coming. Am. Rev. Respir. Dis. 140:1788-1795.
23. Palmer, S., and A. S. Hamblin. 1993. Increased CD11/CD18 expression on the peripheral blood leukocytes of patients with HIV disease: relationship to disease severity. Clin. Exp. Immunol. 93:344-349.
24. Pitrak, D. L., P. M. Bak, P. DeMarais, R. M. Novak, and B. R. Anderson. 1993. Depressed neutrophil superoxide production in human immunodeficiency virus infection. J. Infect. Dis. 167:1406-1410.
25. Pitrak, D. L., H. Chie Tsai, K. M. Mullane, S. H. Sutton, and P. Stevens. 1996. Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome. J. Clin. Invest. 98:2714-2719.
26. Roitt, I., J. Brostoff, and D. Male. 1989. Adaptive and innate immunity, p. 1.1. In I. Roitt, J. Brostoff, and D. Male (ed.), Immunology. Glower Medical Publishing, New York, N.Y.
27. Samanta, A. K., J. J. Oppenheim, and K. Matsushima. 1990. Interleukin-8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils. J. Biol. Chem. 265:183-189.
28. Schröder, J.-M., U. Mrowietz, E. Morita, and E. Christophers. 1987. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J. Immunol. 139:3474-3483.
29. Shalekoff, S., C. T. Tiemessen, C. M. Gray, and D. J. Martin. 1998. Depressed phagocytosis and oxidative burst in polymorphonuclear leukocytes from individuals with pulmonary tuberculosis with or without HIV-1 infection. Clin. Diagn. Lab. Immunol. 5:41-44.
30. Stewart, A. G., T. Harris, M. De Nichilo, and A. F. Lopez. 1991. Involvement of leukotriene B4 and platelet activating factor in cytokine priming of human polymorphonuclear neutrophils. Immunology 72:206-212.
31. Thea, D. M., R. Porat, K. Nagimbi, M. Baangi, M. E. St. Louis, G. Kaplan, C. A. Dinarello, and G. T. Keusch. 1996. Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1. Ann. Intern. Med. 124:757-762.
32. Valone, F. H., D. G. Payan, D. I. Abrams, and E. J. Goetzl. 1984. Defective polymorphonuclear leukocyte chemotaxis in homosexual men with persistent lymph node syndrome. J. Infect. Dis. 150:267-271.
33. Wenisch, C., B. Parschalk, K. Zedwitz-Liebenstein, W. Graninger, and A. Rieger. 1996. Dysregulation of the polymorphonuclear leukocyte-Candida spp. interaction in HIV-positive patients. AIDS 10:983-987.
34. Whalen, C., C. R. Horsburgh, D. Hom, C. Lahart, M. Simberkoff, and J. Ellner. 1995. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am. J. Respir. Crit. Care Med. 151:129-135.